KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,855,000 | +60.6% | 234,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $1,155,000 | +39.7% | 234,000 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $827,000 | -77.4% | 234,000 | -36.2% | 0.00% | -75.0% |
| Q2 2015 | $3,658,000 | -28.9% | 367,000 | -9.1% | 0.01% | -36.8% |
| Q1 2015 | $5,148,000 | +16.9% | 403,800 | +29.6% | 0.02% | +35.7% |
| Q4 2014 | $4,403,000 | – | 311,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |